XPR1
Basic information
Region (hg38): 1:180632022-180890279
Links
Phenotypes
GenCC
Source:
- basal ganglia calcification, idiopathic, 6 (Strong), mode of inheritance: AD
- basal ganglia calcification, idiopathic, 6 (Strong), mode of inheritance: AD
- basal ganglia calcification, idiopathic, 6 (Moderate), mode of inheritance: AD
- bilateral striopallidodentate calcinosis (Supportive), mode of inheritance: AD
- basal ganglia calcification, idiopathic, 6 (Moderate), mode of inheritance: AD
- basal ganglia calcification, idiopathic, 6 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Basal ganglia calcification, idiopathic, 6 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 886353; 25938945 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the XPR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 47 | 53 | ||||
missense | 77 | 80 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 7 | 5 | 2 | 14 | ||
non coding | 29 | 39 | 69 | |||
Total | 0 | 2 | 83 | 78 | 45 |
Variants in XPR1
This is a list of pathogenic ClinVar variants found in the XPR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-180632070-G-A | Benign (Jul 17, 2018) | |||
1-180632227-C-G | Uncertain significance (Apr 25, 2023) | |||
1-180632267-T-C | Basal ganglia calcification, idiopathic, 6 | Conflicting classifications of pathogenicity (Feb 15, 2024) | ||
1-180632280-C-T | Likely benign (Mar 29, 2023) | |||
1-180632288-G-C | Likely benign (Jul 05, 2023) | |||
1-180632290-G-A | Likely benign (Dec 04, 2021) | |||
1-180682347-T-A | Likely benign (Feb 11, 2023) | |||
1-180682383-A-T | Likely benign (Jun 03, 2021) | |||
1-180682478-G-A | Likely benign (Aug 11, 2018) | |||
1-180682660-A-C | Likely benign (Mar 01, 2020) | |||
1-180787733-A-G | Likely benign (May 31, 2023) | |||
1-180787752-G-C | Uncertain significance (Jul 19, 2022) | |||
1-180787761-G-A | Uncertain significance (Jun 27, 2023) | |||
1-180787769-A-G | Likely benign (Jun 24, 2023) | |||
1-180787774-A-G | Uncertain significance (Mar 05, 2023) | |||
1-180787802-G-C | Uncertain significance (Oct 03, 2023) | |||
1-180787813-C-G | Uncertain significance (Nov 21, 2022) | |||
1-180787819-A-G | Uncertain significance (Jul 24, 2019) | |||
1-180787853-A-G | Uncertain significance (May 23, 2023) | |||
1-180787871-CT-C | Benign (Feb 08, 2022) | |||
1-180787871-C-CT | Benign (Jan 30, 2024) | |||
1-180787871-C-CTT | Benign (Jan 11, 2024) | |||
1-180787920-A-G | Benign (Jul 30, 2018) | |||
1-180787981-G-GT | Benign (Nov 14, 2019) | |||
1-180788008-G-A | Benign (Jul 05, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
XPR1 | protein_coding | protein_coding | ENST00000367590 | 15 | 258248 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000130 | 125743 | 0 | 4 | 125747 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.23 | 218 | 400 | 0.545 | 0.0000227 | 4583 |
Missense in Polyphen | 38 | 161.23 | 0.23569 | 1775 | ||
Synonymous | 0.719 | 131 | 142 | 0.923 | 0.00000719 | 1331 |
Loss of Function | 5.60 | 2 | 40.4 | 0.0495 | 0.00000236 | 427 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in phosphate homeostasis. Mediates phosphate export from the cell (PubMed:23791524, PubMed:25938945). Binds inositol hexakisphosphate (Ins6P) and similar inositol polyphosphates, such as 5-diphospho-inositol pentakisphosphate (5- InsP7); these are important intracellular signaling molecules (PubMed:27080106). {ECO:0000250|UniProtKB:Q9Z0U0, ECO:0000269|PubMed:23791524, ECO:0000269|PubMed:25938945, ECO:0000269|PubMed:27080106}.;
- Disease
- DISEASE: Basal ganglia calcification, idiopathic, 6 (IBGC6) [MIM:616413]: A form of basal ganglia calcification, an autosomal dominant condition characterized by symmetric calcification in the basal ganglia and other brain regions. Affected individuals can either be asymptomatic or show a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures, and chronic headache. Serum levels of calcium, phosphate, alkaline phosphatase and parathyroid hormone are normal. The neuropathological hallmark of the disease is vascular and pericapillary calcification, mainly of calcium phosphate, in the affected brain areas. {ECO:0000269|PubMed:25938945}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.204
Intolerance Scores
- loftool
- 0.144
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.77
Haploinsufficiency Scores
- pHI
- 0.423
- hipred
- Y
- hipred_score
- 0.713
- ghis
- 0.557
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.940
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Xpr1
- Phenotype
- immune system phenotype;
Zebrafish Information Network
- Gene name
- xpr1b
- Affected structure
- macrophage
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;response to virus;cellular phosphate ion homeostasis;phosphate ion transmembrane transport;viral entry into host cell
- Cellular component
- Golgi apparatus;plasma membrane;integral component of membrane;intrinsic component of plasma membrane
- Molecular function
- inositol hexakisphosphate binding;virus receptor activity;transmembrane signaling receptor activity;G protein-coupled receptor activity;phosphate ion transmembrane transporter activity;efflux transmembrane transporter activity;signaling receptor activity